The Deal
Sunday, November 8, 
9:40 am

Psilos Group's Waxman on controlling healthcare costs

  Share     E-Mail    Discussion    Print Story

Dr. Albert Waxman, the CEO of venture capital firm Psilos Group, spoke at The Deal's Healthcare Dealmaking Symposium about ways to control healthcare costs.

"There are 10 to 15 things that [the government] can do to radically control costs. ... Waste is a huge issue. Chronic care, unnecessary procedures and the like are going to have to be addressed," Waxman commented. "I don't mean to be Polly Anna-ish, but it's hard to be in the industry and not see that 30% of the money is wasted.

Continue reading below

Also on Dealscape

"We spend too much money on healthcare, and it's going to take serious work to change the system," he continued. "But you've got to go through the process of the congressional sausage factory and see what comes out of that.

"I agree that it's hard to ask the government to manage anything, but our economy is dependent on fixing this problem," Waxman suggested. "They have to make an educated attempt at healthcare reform, not a political reform." - George White

See earlier comments on Obama health reform from Apax's Gumina





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.